|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 4/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
164,320,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.000001 - $0.8281 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ViewRay designs, manufactures and markets the ViewRay MRIdian® MRI-Guided Radiation Therapy System. MRIdian is built upon a proprietary magnetic resonance imaging (MRI) system to address the challenges and clinical workflow for radiation oncology. The MRIdian MR-Guided Radiation Therapy System integrates diagnostic-quality MRI with radiation therapy delivery to enable on-table adaptive treatments with real-time tissue tracking and automatic beam gating. Co.'s generations of the MRIdian are: the MRIdian with Cobalt-60 based radiation beams and MRIdian Linac, with linear accelerator or linac based radiation beams.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
71,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$252,506 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
4 |
| Total Shares Sold |
0 |
0 |
13,487,227 |
13,529,227 |
| Total Sell Value |
$0 |
$0 |
$844,275 |
$1,017,735 |
| Total People Sold |
0 |
0 |
8 |
9 |
| Total Sell Transactions |
0 |
0 |
11 |
12 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Stassen Zachary William |
Chief Financial Officer |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
112,660 |
457,963 |
|
- |
|
| Dempsey James F. |
Chief Scientific Officer |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
104,613 |
735,409 |
|
- |
|
| Dempsey James F. |
Chief Scientific Officer |
• – – |
2021-03-01 |
4 |
D |
$4.66 |
$29,554 |
D/D |
(6,342) |
630,796 |
|
- |
|
| Spencer Phillip M |
Director |
– • – |
2021-02-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,000 |
|
17% |
|
| Spencer Phillip M |
Director |
– • – |
2021-02-09 |
4 |
A |
$4.91 |
$47,666 |
D/D |
9,708 |
13,708 |
|
- |
|
| Grossman D Keith |
Director |
– • – |
2021-01-04 |
4 |
A |
$6.41 |
$49,998 |
I/I |
7,800 |
100,855 |
|
- |
|
| Castelein Caley |
Director |
– • – |
2021-01-04 |
4 |
A |
$6.41 |
$54,998 |
D/D |
8,580 |
795,095 |
|
- |
|
| Moore Daniel Jeffrey |
Director |
– • – |
2021-01-04 |
4 |
A |
$6.41 |
$94,996 |
D/D |
14,820 |
136,984 |
|
- |
|
| Wilensky Gail R |
Director |
– • – |
2021-01-04 |
4 |
A |
$6.41 |
$49,998 |
D/D |
7,800 |
113,791 |
|
- |
|
| Xie Yili Kevin |
Director |
– • – |
2020-12-31 |
4 |
A |
$3.82 |
$9,382 |
D/D |
2,456 |
149,323 |
|
- |
|
| Castelein Caley |
Director |
– • – |
2020-12-31 |
4 |
A |
$3.82 |
$9,630 |
D/D |
2,521 |
786,515 |
|
- |
|
| Moore Daniel Jeffrey |
Director |
– • – |
2020-12-31 |
4 |
A |
$3.82 |
$19,803 |
D/D |
5,184 |
122,164 |
|
- |
|
| Wilensky Gail R |
Director |
– • – |
2020-12-31 |
4 |
A |
$3.82 |
$11,735 |
D/D |
3,072 |
105,991 |
|
- |
|
| Drake Scott William |
President & CEO |
• • – |
2020-11-10 |
4 |
B |
$3.23 |
$499,906 |
D/D |
155,000 |
3,662,310 |
2.81 |
27% |
|
| Matin Shahriar |
Chief Operating Officer |
• – – |
2020-10-24 |
4 |
D |
$3.05 |
$279,459 |
D/D |
(91,626) |
1,688,482 |
|
- |
|
| Dempsey James F. |
Chief Scientific Officer |
• – – |
2020-10-24 |
4 |
D |
$3.05 |
$115,937 |
D/D |
(38,012) |
637,138 |
|
- |
|
| Drake Scott William |
President & CEO |
• • – |
2020-10-24 |
4 |
D |
$3.05 |
$226,209 |
D/D |
(74,167) |
3,507,310 |
|
- |
|
| Matin Shahriar |
Chief Operating Officer |
• – – |
2020-07-22 |
4 |
D |
$2.45 |
$207,422 |
D/D |
(84,662) |
1,780,108 |
|
- |
|
| Drake Scott William |
President & CEO |
• • – |
2020-07-22 |
4 |
D |
$2.45 |
$414,841 |
D/D |
(169,323) |
3,581,477 |
|
- |
|
| Castelein Caley |
Director |
– • – |
2020-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
52,752 |
783,994 |
|
- |
|
| Roberts Brian K |
Director |
– • – |
2020-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
52,752 |
112,002 |
|
- |
|
| Johnson B Kristine |
Director |
– • – |
2020-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
52,752 |
151,968 |
|
- |
|
| Grossman D Keith |
Director |
– • – |
2020-06-15 |
4 |
A |
$0.00 |
$0 |
I/I |
52,752 |
93,055 |
|
- |
|
| Wilensky Gail R |
Director |
– • – |
2020-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
52,752 |
102,919 |
|
- |
|
| Xie Yili Kevin |
Director |
– • – |
2020-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
52,752 |
146,867 |
|
- |
|
318 Records found
|
|
Page 6 of 13 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
